Allergy/Immunology 1 Flashcards
Plasma cells (3)
- Secrete antibodies, antiglobulins
- New guidelines say need to check IgE levels before giving peanuts at 6 months
- Introduce only if you do a skin prick test; way of introducing peanuts earlier
IgA (5)
- IgA is lining your respiratory tract; takes 6 weeks for tract to regenerate
- Kids that are IgA deficient – the most common form of immune deficiency
- Think about with recurrent respiratory diseases, sinusitis, otitis
- Provides antibodies in mucous and saliva
- Activates alternate compliment pathway
IgE (2)
- plays a role in allergy, mast cell degranulation, immediate release of histamine
- Main player = degranulation of mast cell
IgG (2)
- Long term antibodies
2. Measles outbreak = once you get the disease have long-term protection*
IgM
acute antibody; take an example of EBV you do not order an IgM at the very beginning and you want to wait 6-7 days
Allergic Reactions (3)
- Allergy – Results as part of a specific acquired alteration in the body that has an immunologic basis.
- Union of antigen and antibody – Cascade of events that culminates in biochemical reactions.
- All four types of allergic reactions – Mediated by circulating or cellular antibodies
TH1 Cells (3)
- Infectious
- Seeing more allergies = vaccinations have caused less infections and a shift towards TH2 end
- Kids who live in farms get exposed early and shift towards TH1 end
Mast cell chemical activation: histamine (2)
- Bronchoconstriction, mucus production, vasodilatation, pruritus, arrhythmias, chemoattractant
- Rales in asthma because of mucous production
Mast cell chemical activation: Prostaglandins D-2 (PGD2)
Bronchoconstrictor, peripheral vasodilator, coronary vasoconstrictor, neutrophil chemoattractant
Mast cell chemical activation: platelet activating factor
Bronchoconstrictor, vasodilator, chemotaxis, degranulation of neutrophils
Mast cell chemical activation: leukotriene B4
Neutrophil chemotaxis
-Too many neutrophils cause a lot of destruction
Mast cell chemical activation: Leukotriene C4 and Leukotriene D 4(LTC4 & LTD4)
Bronchoconstrictor, increase vascular permeability, chemotaxis
Type 1 Allergic Reaction (6)
- IgE mediated!
- Local and systemic manifestations resulting interaction between antigen and tissue cells
- Allergen interacts with IgE antibody on the surface of mast cells and basophils resulting in the cross link of IgE, Fc€RI receptor apposition and mediator release from these cells
- Histamine and release of IgE = type 1 allergic reaction and can cause urticaria
- Anaphylaxis = type 1 reaction
- Systemic and local reactions, cardiac involvement, GI involvement
- Involves IgE and histamine
Step 1 of IgE mediated sensitivity (4)
Type 1 allergic reaction
- Sensitization
- Initial exposure leading to increase in allergen specific IgE
- Cell mediator symptoms increase
- Occurs within minutes of subsequent exposure to antigen with release of mediators such as histamine
Step 2 of IgE mediated sensitivity (2)
- Early Phase minutes
2. Mast cells release histamine and leukotrienes and cytokines
Step 3 of IgE mediated sensitivity (3)
- Late phase: hours
- Late phase = one of the reasons if mom doesn’t fill prescription is even worse
- Inflammation of respiratory tract
What produces IgE?
plasma cells
Clinical criteria for diagnosis of anaphylaxis (3)
- Acute onset of an illness (minutes to several hours) with involvement of skin, mucosal tissues, or both (e.g. generalized hives, pruritus, or flushing) and at least one of the following: respiratory compromise or reduced BP or associated symptoms of end-organ dysfunction
- Two or more of the following that occur rapidly after exposure to a likely allergen for that patient – involvement of the skin-mucosal tissue, respiratory compromise, reduced BP, or persistent GI symptoms
- Reduced BP after exposure to a known allergen or greater than 30% decrease in systolic BP
Factors that intensify anaphylaxis or interfere with treatment (5)
- Presence of asthma
- Underlying cardiac disease, especially with rapid infusion of allergen, older individual
- Concominant therapy with B-adrenergic, b1/b2 antagonists, monaomine oxidase inhibitors, tricyclics, ACE inhibitors, ARBs
- delay or inadequate dose of Epi
- psychiatric disease
Clinical manifestations of type 1 reaction: two phases (6)
- Immediate allergic reactions
a. Sneezing
b. Hives
c. Wheezing
d. Vomiting
e. Anaphylaxis - Late-phase response
a. Release of toxic mediators by activated eosinophils and mononuclear cells recruited to the site of the acute allergic reaction
what causes the late phase reaction? (9)
- Mast cells
- T cells
- Mediators at post capillary endothelial cells
- Adhesion of circulating leukocytes
- Infiltration of tissues by eosinophils, neutrophils and basophils
* Eosinophils produce mediators that promote tissue damage - Outflow of plasma leading to local edema.
- TH2 lymphocytes release cytokines (interleukon and interferon) that promote IgE production
- Eosinophil chemoattraction
- Increased numbers of mucosal mast cells
Urticaria
PART OF TYPE 1 REACTIONS; hallmark is they move
Clues of allergic rhinitis (4)
- nasal itching
- mouth breathing
- allergic shiners
- repeated nose rubbing “allergic salute”
Type II Allergic Reaction (2)
CYTOTOXIC REACTION
- IgG or IgM antibody is directed again antigens on the individual own tissue
- The binding of the antibody to the cell surface results in complement activation, signaling white blood cell influx and tissue injury